OUR SOLUTIONS

Explore The Transformative Potential
Of Biomolecular Condensates For Drug Discovery

Condensate-Based Drug Discovery Strategies

We offer multiple condensate-based drug discovery strategies for many untargetable drug targets. The preferred strategy will depend on your desired pharmacological outcome and on the composition, structure, and function of the given condensate.

Condensate Therapeutics for Targeted Diseases

Our erxperts are committed to developing innovative condensate therapeutics for difficult-to-treat diseases, including neurodegenerative diseases, cancers, cardiovascular diseases, and infectious diseases, etc.

Condensates-Resident Small Molecules Therapeutic Solutions

We offer professional condensate-resident small molecules therapeutic solutions to find small molecules that bind directly to the proteins that make up the biomolecular condensate itself.

RNA Therapeutic Solutions Targeting Condensate

We provide professional condensate-targeted RNA therapeutic solutions to modify or solubilize pathological condensates, and synthesize engineered condensates to restore losses in disease.

OUR SCIENCES

We Turn Condensates Biology Into Breakthrough Drugs

CD BioSciences is a company that applies new insights into biomolecular condensates to drug discovery, aiming to translate condensate biology into breakthrough therapies. We have developed a condensate-based drug discovery platform that is leading the way in the understanding of condensates and the development of new drugs to restore abnormal condensate function in multiple ways.

Functional Regulation

RNA metabolism.
Ribosome biogenesis.
DNA damage response.
Signal transduction.

Adjustment Protocols

Altering the concentration of condensates components.
Alters post-translational modification or order of condensates.
Expanding the choice of drug targets.

Related Diseases

Neurodegenerative diseases.
Cancer.
Infectious diseases.
Inflammatory diseases.
Cardiovascular diseases.

INNOVATIVE DISCOVERIES

Enabling The Targeting Of "Untargetable" Proteins

Like protein degradation, gene editing, and targeted RNA regulation technologies, our goal is to provide new drug development strategies for "non-druggable" drug targets (e.g., transcription factors, phosphatases, protein-protein interactions) through biomolecular condensates. Depending on the disease of choice, we offer several technical pathways as follows:

Repairing a condensatopathy.

Disrupting the normal functioning of a condensate implicated in disease.

Preventing a target from functioning either by disabling it within its native condensate or by de-partitioning the target from its native condensate.

CD BioSciences is a company conducting biomolecular condensates targeted innovative drugs. We integrate the latest advances in physics, chemistry, biology, and machine learning to address some of the most fundamental challenges in health and disease today.

Address:

Tel:

Email:

Explore The Transformative Potential Of Biomolecular Condensates For Drug Discovery